Most patient organizations consider drug companies "unreliable". This is what emerges from an English survey conducted by PatientView. In 2008, only 37% of 665 patient organizations believed pharmaceutical companies were "trustworthy" and less than a quarter have seen any improvement since then. European companies have the best results, while US and UK companies are in last place. The 55% of organizations do not believe there has been a real increase in transparency over the past year.
The Financial Times online – 12/03/2010 , The Financial Times Pag.15 – 12/03/2010 
